Inhibition by somatostatin of the growth hormone, but not corticotropin response to angiotensin II in normal men

Human Heredity

Volumn 45, Issue 6, 1996, Pages 269-272

  Volpi, R ^a   Chiodera, P ^b   Capretti, L ^c   Caiazza, A ^d   Caffarri, G ^e   Magotti, M G ^b   Boni, S ^a   Coiro, V ^a  

^a University Clinics of Internal Medicine   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c University Clinics of Endocrine Unit   (Italy)

^d Hospital of Fidenza   (Italy)

^e Hospital of Guastalla   (Italy)

Author keywords

Angiotensin II; Corticotropin; Growth hormone; Somatostatin

Indexed keywords

ANGIOTENSIN; CORTICOTROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOSTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029944969     PISSN: 00015652     EISSN: 14230062     Source Type: Journal    
DOI: 10.1159/000184804     Document Type: Article

References (19)

1. Wright JW, Harding JW: Regulatory role of brain angiotensin in the control of physiological and behavioral responses. Brain Res Rev 1992;17:227-262.
2. degli Uberti EC. Transforini G. Margutti A, Rossi R. Ambrosio MR. Pansini R: Stimulation of growth hormone and corticotropin release by angiotensin II in man. Metabolism 1990:39:1063-1067.
3. Patel YC, Srikant CP: Somatostatin mediation of adenohypophysial secretion. Ann Rev Physiol 1986;48:551-567.
4. Aguilera G, Hardwood JP, Catt KJ: Somatostatin modulates effects of angiotensin II in adrenal glomerulosa zone. Nature 1982:292:262-263.
5. Boscaro M, Scaroni C, Edward CRW, Mantero F: Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: In vitro studies. J Endocrinol Invest 1982;5:173-177.
6. Jones CR, Millar JA, Lawrie C, Summer DJ, Reid JL: Specific inhibition of aldosterone responses to endogenous and exogenous angiotensin II by somatostatin. Clin Endocrinol 1984;21:272-284.
7. Aguilera G, Parker DS, Catt KJ: Characterization of somatostatin receptors in the rat adrenal glomerulose zone. Endocrinology 1982:111: 1376-1384.
8. Gelato MG, Pescovitz OH, Cassorla F, Loriaux DL, Merriant GR: Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women. J Clin Endocrinol Metab 1984:59:197-201.
9. Rayyis SS, Horton R: Effect of angiotensin II on adrenal and pituitary function in man. J Clin Endocrinol Metab 1971;32:539-546.
10. Uhlich E, Weber P, Eigler J, Groschell-Stewardo U: Angiotensin stimulated AVP-release in humans. Klin Wochenschr 1975:53:177-180.
11. Usberti M, Federico S, Di Minilo G, Ungaro B, Ardillo G, Pecoraro C, Cianciaruso B, Cerbone AM, Cirillo F, Pannain M, Gargiulo A, Andreucci VE: Effects of angiotensin II on plasma ADH. prostaglandin synthesis and water excretion in normal humans. Am J Physiol 1985:17: F254-F259.
12. Coiro V, Chioderà P: Inhibition by sodium valproate of the arginine-vasopressin and adreno-corticotropin responses to angiotensin II in normal men. Brain Res 1989;491:169-172.
13. Tuomisto J, Mannisto P: Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 1985:37:248-332.
14. Volpi R, Chioderà P, Rossi G, Colla R, Caffarri G, Caiazza A, Marcato A, Coiro V: Somatostatin does not modulate arginine-vasopressin and oxytocin responses to angiotensin II. Ncuroen-docrinol Lett 1992;14:153-157.
15. Brown MR, Rivier C, Vale W: Central nervous system regulation of adrenocorticotropin secretion: role of somatostatin. Endocrinology 1984; 114:1546-1549.
16. Petraglia F, Facchinetti F, D'Antbrogio G, Volpe A, Genazzani AR: Somatostatin and oxytocin infusion inhibits the rise of plasma β-endorphin and p-lipotropin and cortisol induced by insulin hypoglycaemia. Clin Endocrinol 1986:24:609-616.
17. Stafford PJ, Kopelman PG, Davidson K, McLoughiin L, White A, Rees LH, Besser GM, Coy DH, Grossman A: The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. Clin Endocrinol 1989;30:661-666.
18. Benker G, Hackenberg K, Hamburger B, Rein-wein D: Effects of growth hormone release inhibiting hormone and bromocriptine (CB 154) in states of abnormal pituitary-adrenal function. Clin Endocrinol 1976:5:187-190.
19. Christensen NJ, Christensen SE, Hansen AP, Luncboek K: The effect of somatostatin on plasma noradrenaline and plasma adrenaline concentrations during exercise and hypoglycemia. Metabolism 1975:24:1267-1272.